Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G1B | P04054 | 1/20 | 0.51 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | JAK1 | P23458 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14359456 | 0.93 | LMNA (0.47) | PLA2G1BATG4BLMNAALDH1A1HTT | |
| SCHEMBL14359594 | 0.84 | ACHE (0.50) | ALDH1A1GAAHPGDKDM4EMAPK1 | |
| SCHEMBL16365845 | 0.84 | PLA2G1B (0.51) | PLA2G1BATG4BLMNAALDH1A1HTT | |
| SCHEMBL20343486 | 0.77 | LMNA (0.44) | LMNAMAPK1JAK1 | |
| SCHEMBL12744721 | 0.77 | CHRNB2 (0.60) | — | |
| SCHEMBL18390258 | 0.73 | CHRM1 (0.63) | GAA | |
| SCHEMBL29522101 | 0.73 | CHRM1 (0.63) | GAA | |
| SCHEMBL18171456 | 0.73 | DPP4 (0.46) | LMNARAB9AKDM4EMAPK1 | |
| SCHEMBL27780237 | 0.73 | DPP4 (0.46) | LMNARAB9AKDM4EMAPK1 | |
| SCHEMBL14236778 | 0.73 | PLA2G1B (0.87) | PLA2G1BATG4BALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9162972-B2 | Method for production of hydroxycarboxylic acid amide compounds and novel arylboronic acid compound | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-10-20 | — | — | US | disclosed |
| US-9162972-B2 | Method for production of hydroxycarboxylic acid amide compounds and novel arylboronic acid compound | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-10-20 | — | — | US | disclosed |
| US-20150011766-A1 | METHOD FOR PRODUCTION OF HYDROXYCARBOXYLIC ACID AMIDE COMPOUNDS AND NOVEL ARYLBORONIC ACID COMPOUND | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-01-08 | — | — | US | disclosed |
| US-20150011766-A1 | METHOD FOR PRODUCTION OF HYDROXYCARBOXYLIC ACID AMIDE COMPOUNDS AND NOVEL ARYLBORONIC ACID COMPOUND | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2015-01-08 | — | — | US | disclosed |
| EP-2816026-A1 | PRODUCTION METHOD FOR HYDROXY-CARBOXYLIC ACID AMIDE COMPOUND, AND NOVEL ARYLBORONIC ACID COMPOUND | National University Corporation Nagoya University (JP) | 2014-12-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011766-A1 | METHOD FOR PRODUCTION OF HYDROXYCARBOXYLIC ACID AMIDE COMPOUNDS AND NOVEL ARYLBORONIC ACID COMPOUND | HCAR2, HCAR1, NCOR2 | PLA2G1B 2188/4885ATG4B 2250/4885LMNA 3595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.